Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Mantle-Cell 6Leukemia, Myelomonocytic, Acute 6Leukemia, Monocytic, Acute 6Leukemia, Erythroblastic, Acute 6Congenital Abnormalities 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Leukemia, Megakaryoblastic, Acute 5Waldenstrom Macroglobulinemia 4Lymphoma, Non-Hodgkin 4Lymphoma, B-Cell, Marginal Zone 4Multiple Myeloma 3Lymphoma 3Leukemia, Prolymphocytic 3Burkitt Lymphoma 3Sezary Syndrome 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Immunoblastic Lymphadenopathy 2

Interventions

alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Tumor Lysis Syndrome × alvocidib × Clear all
NCT00445341 2018-01-30

Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
28 enrolled 10 charts
Lymphoid

Lymphoma, Tumor Lysis Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡